Metabolism, Obesity
Conditions
Brief summary
to test safety and efficacy on metabolism, heart rate, blood pressure, TSH (and other blood)and hunger/caloric compensation on ephedra versus placebo
Interventions
DRUGDietPro
DRUGPlacebo
Sponsors
Natural Prescriptions
Johns Hopkins Bloomberg School of Public Health
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
age 18-50, non-smoking, not pregnant (serum), Beck \<15, physician permission
Exclusion criteria
pregnant, lactating, smoker, use of appetite-affecting medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| heart rate | — |
| TSH | — |
| caloric compensation | — |
| metabolic rate | — |
| blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| body composition | — |
| weight | — |
Countries
United States
Outcome results
None listed